No abstract available
MeSH terms
-
Administration, Oral
-
Alleles
-
Aryl Hydrocarbon Hydroxylases / genetics*
-
Asian People
-
Blood Platelets / metabolism
-
Cilostazol
-
Clinical Trials as Topic
-
Coronary Disease / genetics
-
Coronary Disease / therapy
-
Cytochrome P-450 CYP2C19
-
Drug-Eluting Stents
-
Ethnicity
-
Genotype
-
Humans
-
Platelet Aggregation Inhibitors / pharmacology*
-
Platelet Count
-
Prevalence
-
Research Design
-
Tetrazoles / pharmacology*
-
Thrombosis / genetics
-
Treatment Outcome
Substances
-
Platelet Aggregation Inhibitors
-
Tetrazoles
-
Aryl Hydrocarbon Hydroxylases
-
CYP2C19 protein, human
-
Cytochrome P-450 CYP2C19
-
Cilostazol